COMBIGENE Trademark

Trademark Overview


On Monday, July 10, 2023, a trademark application was filed for COMBIGENE with the United States Patent and Trademark Office. The USPTO has given the COMBIGENE trademark a serial number of 98078291. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, July 16, 2024. This trademark is owned by CombiGene AB. The COMBIGENE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment, prevention, and alleviation of central nervous system disorders, chronic pain, pain relief, epilepsy, Alzheimer's Disease, metabolic diseases, and gene therapy; Medical preparations for the treatment, prevention, and alleviation of central nervous system disorders, chronic pain, pain relief, epilepsy, Alzheimer's Disease, metabolic diseases, and gene therapy

Scientific and technological services, namely, research in the field of medicine and the development of pharmaceuticals, and in the field of identification of drug candidates; Gene therapy research; Scientific preclinical and clinical research in the field of medicine and pharmaceuticals; Conducting preclinical and clinical trials for pharmaceutical products
combigene

General Information


Serial Number98078291
Word MarkCOMBIGENE
Filing DateMonday, July 10, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a stylized image of a person in the color green with the stylized wording "COMBIGENE" to the right thereof in the color green-blue.
Goods and ServicesPharmaceutical preparations for the treatment, prevention, and alleviation of central nervous system disorders, chronic pain, pain relief, epilepsy, Alzheimer's Disease, metabolic diseases, and gene therapy; Medical preparations for the treatment, prevention, and alleviation of central nervous system disorders, chronic pain, pain relief, epilepsy, Alzheimer's Disease, metabolic diseases, and gene therapy
Indication of Colors claimedThe color(s) green and blue-green is/are claimed as a feature of the mark.
Goods and ServicesScientific and technological services, namely, research in the field of medicine and the development of pharmaceuticals, and in the field of identification of drug candidates; Gene therapy research; Scientific preclinical and clinical research in the field of medicine and pharmaceuticals; Conducting preclinical and clinical trials for pharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 9, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCombiGene AB
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLidingö 18155
SE

Trademark Events


Event DateEvent Description
Thursday, July 13, 2023NEW APPLICATION ENTERED
Wednesday, August 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 10, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 19, 2024ASSIGNED TO EXAMINER
Friday, April 19, 2024NON-FINAL ACTION WRITTEN
Friday, April 19, 2024NON-FINAL ACTION E-MAILED
Friday, April 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 19, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, September 19, 2024TEAS VOLUNTARY AMENDMENT RECEIVED